TransMedics Group

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade TransMedics Group 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About TMDX

TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. 

CEO
Waleed H. Hassanein
CEOWaleed H. Hassanein
Employees
728
Employees728
Headquarters
Andover, Massachusetts
HeadquartersAndover, Massachusetts
Founded
1998
Founded1998
Employees
728
Employees728

TMDX Key Statistics

Market cap
4.70B
Market cap4.70B
Price-Earnings ratio
55.45
Price-Earnings ratio55.45
Dividend yield
Dividend yield
Average volume
505.14K
Average volume505.14K
High today
$138.97
High today$138.97
Low today
$134.25
Low today$134.25
Open price
$137.60
Open price$137.60
Volume
691.93K
Volume691.93K
52 Week high
$156.00
52 Week high$156.00
52 Week low
$55.00
52 Week low$55.00

Stock Snapshot

With a market cap of 4.7B, TransMedics Group(TMDX) trades at $138.00. The stock has a price-to-earnings ratio of 55.45.

During the trading session on 2026-01-09, TransMedics Group(TMDX) shares reached a daily high of $138.97 and a low of $134.25. At a current price of $138.00, the stock is +2.8% higher than the low and still -0.7% under the high.

Trading activity shows a volume of 691.93K, compared to an average daily volume of 505.14K.

The stock's 52-week range extends from a low of $55.00 to a high of $156.00.

The stock's 52-week range extends from a low of $55.00 to a high of $156.00.

TMDX News

Simply Wall St 2d
Does TransMedics Logistics Integration Reframe Its Risk Reward Profile In Organ Transplantation?

In recent days, TransMedics Group has experienced marked trading volatility as it pursues expansion of its organ-care platform and integrates logistics services...

Does TransMedics Logistics Integration Reframe Its Risk Reward Profile In Organ Transplantation?
Simply Wall St 3d
Assessing TransMedics Group Valuation As Investors Reassess Growth Potential And Execution Risks

Advertisement Why TransMedics Group is back in focus TransMedics Group (TMDX) is back on many watchlists after recent stock swings tied to investor reassessme...

Assessing TransMedics Group Valuation As Investors Reassess Growth Potential And Execution Risks

Analyst ratings

77%

of 13 ratings
Buy
76.9%
Hold
23.1%
Sell
0%

People also own

Based on the portfolios of people who own TMDX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.